Featured News
Traverse Biosciences Executes Exclusive, Worldwide License Agreement
Mar 16 2015
NEW YORK, NY
Traverse Biosciences, founded by Joseph Scaduto - one of the Center for Biotechnology's first BioEntrepreneurs-in-Residence, annou
Learn MoreMillennial Materials and Devices Presenting at NY Business Plan Competition FinalsApr 8 2015
Gaurav Lalwani, PhD, Biomedical Engineering department at Stony brook University and Center for Biotechnology Fundamentals Program
Learn MoreNew Mathematical Model May Improve Drug Discovery - Study Co-Authored by CFB's Dr. Eleanor AllenApr 22 2015
A new mathematical model that uses drug-target kinetics to predict how drugs work in vivo may provide a foundation to improve drug
Learn More-
NYS Governor Hochul Announces $300M Investment in SUNY at Stony Brook’s Quantum Research and Innovation HubSeptember 19, 2025
New York State is making a major investment in the future of technology with a $300 million commitment to Stony Brook University to establish a first-of-its-kind Quantum Research and Innovation Hub. Building on Stony Brook’s leadership as home to the …
Learn More -
Center for Biotechnology Announces Redesignation as New York State Center for Advanced TechnologyJuly 17, 2025
The Redesignation brings $10 million in funding to drive innovation, company formation, and economic growth. The Center for Biotechnology (CFB) has announced its re-designated as a Center for Advanced Technology (CAT) by Empire State Development‘s Division of Science, Technology and …
Learn More -
NYSTAR-supported AI Advancements Make Strides in Fight Against CancerJune 30, 2025
Envisagenics, supported by the Center for Biotechnology at Stony Brook University, is a pioneering biotech company that has been applying AI to drug target discovery for over a decade. In drug development, targets are molecular structures (often proteins) where drugs …
Learn More
Upcoming Events
No Events